In diet-induced obesity, hypothalamic and systemic inflammatory factors trigger intracellular mechanisms that lead to resistance to the main adipostatic hormones, leptin and insulin. Tumor necrosis factor-alpha (TNF-) is one of the main inflammatory factors produced during this process and its mechanistic role as an inducer of leptin and insulin resistance has been widely investigated. Most of TNF- inflammatory signals are delivered by TNFR1; however, the role played by this receptor in the context of obesity-associated inflammation is not completely known. Here, we show that TNFR1 knockout (TNFR1 KO) mice are protected from diet-induced obesity due to increased thermogenesis. Under standard rodent chow or high-fat diet, TNFR1 KO gain significantly less body mass in spite of increased caloric intake. Visceral adiposity and mean adipocyte diameter are reduced and blood concentrations of insulin and leptin are lower. Protection from hypothalamic leptin resistance is evidenced by increased leptininduced suppression of food intake and preserved activation of leptin signal transduction through JAK2, STAT3 and FOXO1. Under high fat diet, TNFR1 KO mice present a significantly increased expression of the thermogenesis-related neurotransmitter, TRH. Further evidence of increased thermogenesis includes the increased O 2 consumption in respirometry measurements, increased expressions of UCP1 and UCP3 in brown adipose tissue and skeletal muscle, respectively, and increased O 2 consumption by isolated skeletal muscle fiber mitochondria. This demonstrates that TNF- signaling through TNFR1 is an important mechanism involved in obesity-associated defective thermogenesis.
In diet-induced obesity, hypothalamic and systemic inflammatory factors trigger intracellular mechanisms that lead to resistance to the main adipostatic hormones, leptin and insulin. Tumor necrosis factor-alpha (TNF-) is one of the main inflammatory factors produced during this process and its mechanistic role as an inducer of leptin and insulin resistance has been widely investigated. Most of TNF- inflammatory signals are delivered by TNFR1; however, the role played by this receptor in the context of obesity-associated inflammation is not completely known. Here, we show that TNFR1 knockout (TNFR1 KO) mice are protected from diet-induced obesity due to increased thermogenesis. Under standard rodent chow or high-fat diet, TNFR1 KO gain significantly less body mass in spite of increased caloric intake. Visceral adiposity and mean adipocyte diameter are reduced and blood concentrations of insulin and leptin are lower. Protection from hypothalamic leptin resistance is evidenced by increased leptininduced suppression of food intake and preserved activation of leptin signal transduction through JAK2, STAT3 and FOXO1. Under high fat diet, TNFR1 KO mice present a significantly increased expression of the thermogenesis-related neurotransmitter, TRH. Further evidence of increased thermogenesis includes the increased O 2 consumption in respirometry measurements, increased expressions of UCP1 and UCP3 in brown adipose tissue and skeletal muscle, respectively, and increased O 2 consumption by isolated skeletal muscle fiber mitochondria. This demonstrates that TNF- signaling through TNFR1 is an important mechanism involved in obesity-associated defective thermogenesis.
Obesity results from the progressive loss of the homeostatic control of food intake and energy expenditure (1, 2) . High consumption of dietary fats is one of the main environmental factors contributing to the worldwide epidemic of obesity (2, 3) . Fatty acids present in the diet can activate systemic and hypothalamic inflammatory signaling, which contribute to obesity-associated resistance to insulin and leptin (4, 5) . Tumor necrosis factor-alpha (TNF-) is one of the main mediators of the inflammatory response in obesity, and is expressed by infiltrating macrophages and adipocytes in the hypertrophic adipose tissue and also by microglia and neurons in the hypothalamus (4) .
TNF- receptor 1 (TNFR1) and TNF- receptor 2 (TNFR2) are the two main transducers of the TNF- signals in most cells and tissues (6) . The receptors share high homology in the extracellular domains, however, in the intracellular region, TNFR1 has a death domain (DD) that mediates its association with the adapter protein, TRADD, while TNFR2 has a TRAF-binding motif (7) . Transducing TNF- signals through either receptor results in the activation of inflammatory gene transcription by NFB and AP1 (7) . In addition, under certain circumstances, pro-apoptotic stimulus can be induced by TNF- (6, 7). The presence of both TNFR1 and TNFR2 is required for full pro-apoptotic signaling, while only the absence of TNFR1, but not of TFNR2 inhibits completely TNF--induced apoptosis (6, 7) .
Although in the context of obesity and insulin resistance, the role played by TNF- has been thoroughly explored, few studies have evaluated the participation of each receptor type individually in this setting. Uysal and colleagues showed that the double knockout for TNFR1 and TNFR2 protects mice from obesity-associated insulin resistance (8) . When knocking out either receptor separately, only the absence of TNFR1 was capable of rescuing ob/ob mice from insulin resistance (9) . Conversely, Schreyer and colleagues reported that both TNFR1 and TNFR2, acting in concert, protect mice from diet-induced insulin resistance (10) .
With the recent demonstration that, in the hypothalamus, TNF- participates in the inflammatory mechanisms that result in obesity-associated leptin and insulin resistance and considering that no previous study has evaluated the role of TNFR1 in diet-induced obesity, we decided to evaluate the effect of high caloric feeding on the phenotype of TNFR1 knockout mice. Here, we show that knocking out TNFR1 protects mice against diet-induced obesity by a mechanism dependent on increased thermogenesis.
Experimental procedures
Antibodies, chemicals and buffers. Reagents for SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting were from Bio-Rad (Richmond, CA, USA). HEPES, phenylmethylsulfonyl fluoride, aprotinin, dithiothreitol, Triton X-100, Tween 20, glycerol and bovine serum albumin (fraction V) were from Sigma (St. Louis, MO, USA). Protein A-Sepharose 6MB was from Pharmacia (Uppsala, Sweden), and nitrocellulose paper (BA85, 0.2 m) was from Amersham (Aylesbury, UK). The reagents for chemiluminescence labeling of proteins in blots were from Amersham (Aylesbury, UK). Leptin was from Calbiochem (San Diego, CA, USA), the anti-TNF- monoclonal antibody infliximab was from Centocor (Horsham, PA, USA) and mouse recombinant TNF- was from Calbiochem (Darmstadt, Germany). Antibodies against phospho-JAK2 (pJAK2, rabbit polyclonal, sc-16566R), SOCS3 (rabbit polyclonal, sc-9023), phospho-Tyr (pTyr, mouse monoclonal, sc-508), STAT3 (rabbit polyclonal, sc-483), -actin (mouse monoclonal, sc-8432), TNFR2 (mouse monoclonal, sc-8041), TRAF2 (mouse monoclonal, sc-137048) and UCP1 (goat polyclonal sc-6529) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); phospho-FKHR (pFOXO1, rabbit polyclonal, recognizing Ser 256, #9461) was from Cell Signaling Technology (Danvers, MA, USA) and cytochrome C (#556433) was from BD Biosciences Pharmingen (San Jose, CA, USA). Chemicals for real-time PCR were from Invitrogen (Carlsbad, CA, USA) and Applied Biosystems (Foster City, CA, USA).
Experimental model and feeding protocols.
Male TNFRp55 -/-(TNFR1 KO) and its respective control C57BL/6J (as suggested by the original breeder -jaxmice.jax.org/strain/ 002818.html), were from The Jackson Laboratory and kindly donated by Dr. J. S. Silva from the University of São Paulo (11) . The mice were bred under specific pathogenfree conditions at the Central Breeding Center of the University of Campinas. In addition, some experiments were performed with eightweek-old (280-300 g) male Wistar rats obtained from the University of Campinas Animal Breeding Center. All animals were handled according to the University guidelines for the use of animals in experimental studies and conform to the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH publication No. 85-23 revised 1996). All experiments were approved by the Ethics Committee at the University of Campinas. The animals were maintained on a 12 h-light/dark cycle. Eightweek-old male TNFR1 KO mice and their controls (C57BL/6J) were divided into two groups paired by age and body mass and assigned to receive two distinct diets for eight weeks: a standard rodent chow (SC) or a high-fat diet (HF) ( Table 1) . Body mass and food intake were measured weekly. In some experiments, mice were treated with a daily dose of TNFR2 antibody (1.25 g, ip) or similar concentration of pre-immune mouse serum, for three weeks. For determination of food intake after leptin treatment, mice were food deprived for 12 h (from 19 h to 7 h) and at 7 h were treated with leptin (10 L/g, 10 -6 M, ip) or saline (10 L/g, ip). Food ingestion was determined over the next 3 h. For all the remaining experiments, animals were food deprived for 6 h.
Icv cannulation. Rats were stereotaxically instrumented using a Stoelting stereotaxic apparatus, according to a method previously described (12) . A cannula was placed in the lateral ventricule and efficiency was tested one week after cannulation by the evaluation of the drinking response elicited by angiotensin II injected icv (13) . Stereotaxic coordinates were: antero-posterior 0.2 mm/ lateral 1.5 mm/ depth 4.0 mm. For the evaluation of the effect of hypothalamic TNF- inhibition, rats were icv treated either with diluent or with infliximab, 0.6 g/dose (2.0 L icv, once a day for seven days)
Hormone and glucose determinations. Blood leptin and insulin concentrations at the end of the experimental period and insulin secreted by isolated pancreatic islets were determined by enzyme-linked immunosorbent assays (Millipore-Linco, Billerica, MA, USA). Blood glucose was determined by colorimetric assay.
Intraperitoneal glucose tolerance test (GTT).
GTT was performed at the end of the experimental period after 6 h fasting. After collection of an unchallenged sample (time 0), a solution of 20% glucose (2.0 g/kg body mass) was administered into the peritoneal cavity. Blood samples were collected from the tail at 30, 60, 90, and 120 min for determination of glucose concentrations. Results are presented as the area under glucose curves.
Insulin tolerance test (ITT)
. Insulin (0.5 U/kg body mass) was administered by ip injection, and blood samples were collected at 0, 4, 8, 12, 16 and 20 min for serum glucose determination. The constant for glucose disappearance rate during the test (Kitt) was calculated using the formula 0.693/t 1/2 . The glucose t 1/2 was calculated from the slope of the least-square analysis of the plasma glucose concentrations during the linear decay phase.
Dynamic insulin secretion studies. Groups of 50 freshly isolated islets were placed on Millipore SW 1300 filters (8.0 μm pore) and perifused in a KRB buffer at a flow rate of 1.0 mL/min for 30 min in the presence of 5.6 mM glucose (basal conditions). After stabilization, the islets were perifused with 5.6 mM or 11.1 mM glucose. Perifusion solutions were gassed with 95% O 2 /5% CO 2 and maintained at 37 ºC. Insulin concentration was measured in the perifusate and expressed as ng/islet.h.
Islet insulin content.
Groups of 4 islets were collected and transferred to tubes containing 1.5 mL deionized water (1.0 mL). After sonication (3 times, 10 seconds pulse), the extracts were used for determination of islet insulin content.
Microscopy.
Mice were fasted for 6 h and killed with an overdose of anesthetic (sodium thiopental). Epididymal white adipose tissue (WAT) and brown adipose tissue (BAT) depots were dissected and assessed by light microscopy. After dissection, specimens were fixed by immersion in 4% formaldehyde in 0.1 mM phosphate buffer, pH 7.4, for 24 h, dehydrated, cleared, and then embedded in paraffin. Serial sections (5m thick) were obtained and then stained by hematoxylin and eosin.
Morphometry. Tissue sections were evaluated with a Zeiss Axiophot light microscope using a x40 objective, and digital images were captured with a Canon PowerShot G5. Mean adipocyte surface area (average surface area of 30 randomly -sorted adipocytes per specimen) were determined using Imagelab Analysis software (version 2.4), as described previously (14) .
Real-time PCR. Hypothalamic total RNA was extracted using Trizol reagent (Life Technologies, Gaithersburg, MD, USA), according to the manufacturer's recommendations. Total RNA was rendered genomic DNA free by digestion with Rnasefree Dnase (RQ1, Promega, Madison, WI, USA). Real-time PCR analysis of gene expression was carried out in an ABI Prism 7500 sequence detection system (Applied Biosystems). The optimal concentration of cDNA and primers, as well as the maximum efficiency of amplification, were obtained through seven-point, 3-fold dilution curve analysis for each gene. Each PCR reaction contained 25-30 ng of reverse-transcribed cDNA (depending on the gene). Primers were purchased from Applied Biosystems and were: UCP3, Mm00494077_m1; TRH, Mm01182425_g1; MCH, Mm01242886_g1; NPY, Mm00445771_m1; POMC, Mm00435874_m1; and, GAPD #4352339E for mouse. The PCR conditions were 2 min at 50ºC; 10 min at 95ºC, followed by 40 cycles at 95ºC for 15 sec and 60ºC for 60 sec. Normalization was obtained by determining the expression of GAPDH in all samples. Real-time data were analyzed using the engine provided by Applied Biosystems.
Oxygen
consumption/carbon dioxide production and respiratory exchange ratio determination. Oxygen consumption/carbon dioxide production and respiratory exchange ratio (RER) were measured in fed animals (mice and rats) through an indirect open circuit calorimeter (Oxymax Deluxe System; Columbus Instruments, Columbus, OH, USA), as described previously (15) .
Tissue extraction, immunoprecipitation, and immunoblotting. Mice were anesthetized by intraperitoneal injection of sodium thiopental and used 10-15 min later, i.e., as soon as anesthesia was assured by the loss of pedal and corneal reflexes. In some experiments, ten or thirty minutes after leptin injection (10L/g, 10 -6 M, ip), hypothalami were removed and homogenized immediately in extraction buffer at 4ºC [1% Triton X-100, 100 mM Tris-HCl (pH 7.4), 100 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium orthovanadate, 2.0 mM PMSF and 0.1 mg aprotinin/mL] with a Polytron PTA 20 S generator (model PT 10/35; Brinkmann Instruments, Westbury, NY, USA). In other experiments, ten minutes after TNF- injection (100L, 10 -8 M, iv), the spleen and thymus were removed and immediately homogenized as described above. Insoluble material was removed by centrifugation for 30 min at 9,000 xg in a 70.Ti rotor (Beckman, Fullerton, CA, USA) at 4ºC. The protein concentrations of the supernatants were determined by the Bradford dye binding method. Aliquots of the resulting supernatants containing 1.0 mg of total protein were used for immunoprecipitation with antibodies against STAT3 or TNFR2 at 4ºC overnight, followed by SDS-PAGE, transfer to nitrocellulose membranes and blotting with anti-pTyr or TRAF2. In direct immunoblot experiments, 0.2 mg of protein extracts were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted with anti-pJAK2, pFOXO1, SOCS3, UCP1 and cytochrome C. The homogeneity of gel loading was always evaluated by blotting the membranes with antibodies against -actin, STAT3 or TNFR2, as appropriate.
Skeletal muscle mitochondria oxygen consumption.
For oxygen consumption measurements, a fragment (2-6 mg) of the soleus muscle was placed into a Petri dish on ice with 1 mL of relaxing solution containing Ca 2+ /EGTA buffer (10 mM), free calcium (0.1 μM), imidazole (20 mM), K + /4-morpholinoethanesulfonic acid (MES) (50 mM), dithiothreitol (DTT; 0.5 mM), MgCl 2 (6.56 mM), ATP (5.77 mM), phosphocreatine (15 mM), pH 7.1, and individual fiber bundles were separated with a sharp forceps. The fiber bundles were permeabilized for 30 min in 3 ml of ice-cold relaxing solution containing saponin (50 μg/mL). The fibers were washed twice for 10 minutes each. The muscle bundles were then immediately transferred into a respirometer (Oxygraph-2k; Oroboros) containing an air-saturated respiration medium at 37°C. The respiration medium (MiR05; Oroboros, Innsbruck, Austria) composition contained sucrose (110 mM), potassium lactobionate (60 mM), EGTA (0.5 mM), MgCl 2 .6H 2 O (3 mM), taurine (20 mM), KH 2 PO 4 (10 mM), HEPES (20 mM), sucrose (110 mM), BSA (2 mg/mL), pH 7.1. The maximal respiration in state 3 was measured in a mixture containing pyruvate + malate (5 mM) and ADP (2 mM). For state 4, olygomicin (1 µg/mL) was added in the assay medium (the Oxygraph-2k is a two-chamber titration-injection respirometer with a limit of oxygen flux detection of 1 pmol/mL.s).
Statistical analysis. Specific protein bands present on the blots were quantified by densitometry. Mean values ± SEM obtained from densitometric scans and from the other experiments were compared utilizing Student's t-test for paired samples or by repeat-measure analysis of variance (one-way or two-way ANOVA) followed by post hoc analysis of significance (Bonferroni test) when appropriate. A p<0.05 was accepted as statistically significant.
Results
Reduced body mass gain and reduced adipose tissue depots in TNFR1 KO. On standard rodent chow, the mean body mass of eight-week-old TNFR1 KO was significantly lower than that of C57BL/6J (21.4±0.5 vs. 28.6±0.4 g, respectively; n = 5, p<0.05). When paired for starting body mass and fed for eight weeks with HF diet, C57BL/6J mice presented a significant increase in body mass as compared to mice treated with CT diet (Fig. 1A) . However, the same diet regimen resulted in no significant change in the body mass of TNFR1 KO (Fig. 1A) . Comparing relative body mass, change on HF diet, a significant difference was observed between C57BL/6J and TNFR1 KO (Fig. 1B) . Protection from diet-induced obesity was independent of reduced food intake. In fact, relative food intake of TNFR1 KO mice was significantly higher than that of C57BL/6J on either diet (Fig. 1C) . In addition, no difference was determined in relative amount of feces (not shown). As a consequence of the protection against diet-induced obesity, TNFR1 KO mice had lower blood concentrations of insulin (Fig. 1D) and leptin (Fig. 1E) , and lower insulin secretion from isolated pancreatic islets (Fig. 1F) , in spite of similar amount of intracellular insulin in pancreatic islets (not shown). Glucose tolerance as determined by a glucose tolerance test was unaffected in TNFR1 KO mice (Fig. 1G) , however, the insulin tolerance test revealed a significantly increased responsiveness to insulin in TNFR1 KO mice fed on HF diet (Fig. 1H) . Finally, TNFR1 KO mice had a smaller epididymal fat depot (Fig.  1I) on the HF diet and reduced mean adipocyte diameter on both diets (Fig. 1J and  1K ).
Protection from diet-induced obesity is not modified by the inhibition TNFR2. Because of the immunological importance of TNFR2 as a transducer of the TNF- signals, we evaluated the effect of the inhibition of this receptor type in TNFR1 KO mice. The activity of TNFR2 is fully preserved in TNFR1 KO mice as shown by the determination of TNF--induced association of TNFR2 with TRAF2 in two important organs of the immune system, the spleen and the thymus (Fig. 2A) . Inhibiting TNFR2 with a competitive antibody produced no effects on body mass (Fig. 2B ) and caloric intake (Fig. 2C ) in either C57BL/6J or TNFR1 KO mice in CT or HF diets. The efficiency of the TNFR2 antibody to inhibit the receptor's function is depicted in Figure 2D .
TNFR1 KO mice are protected against dietinduced hypothalamic leptin resistance. The ability of leptin to inhibit food intake was significantly higher in TNFR1 KO mice on both diet types (Fig. 3A) . This was accompanied by increased leptin-induced JAK2 (Fig. 3B) and STAT3 (Fig. 3D ) tyrosine phosphorylation and FOXO1 (Fig.  3C ) serine phosphorylation. In addition, the protein level of the leptin signal inhibitor, SOCS3, was lower in TNFR1 KO mice (Fig.  3E) . To evaluate the functional consequences of increased hypothalamic leptin responsiveness in TNFR1 KO mice, we determined the mRNA levels of some of the main hypothalamic neurotransmitters involved in the control of food intake and thermogenesis. As shown in Fig. 3F , NPY was lower in TNFR1 KO mice on the CT diet, however, on the HF diet, the level of this orexigenic neurotransmitter was higher than that of the control. The levels of the anorexigenic neurotransmitter, POMC, were significantly lower in TNFR1 KO mice for both diet types (Fig. 3G) . With regard to the thermogenic neurotransmitter TRH, TNFR1 KO mice presented a higher level when fed on HF diet (Fig. 3H) . Finally, the antithermogenic neurotransmitter, MCH, presented similar levels in TNFR1 KO and C57BL/6J mice, independently of diet type (Fig. 3I) .
Increased O 2 consumption in TNFR1 KO mice. Since TNFR1 KO mice were protected from diet-induced obesity even presenting an increased food intake, and considering that the level of the thermogenic neurotransmitter TRH was increased in the hypothalamus of HF diet fed TNFR1 KO mice, we decided to evaluate oxygen consumption/carbon dioxide production and RER. As depicted in Fig. 4A , mutant mice presented a significantly increased oxygen production on both diets. No significant differences in carbon dioxide production and RER were detected between the strains (Fig. 4B and 4C) ; however, under HF diet, both strains presented a reduction of RER (Fig. 4C) indicating a preferential consumption of fat for energy production.
Increased thermogenesis in brown adipose
tissue and skeletal muscle of TNFR1 KO mice. Since hypothalamic TRH level was increased in TNFR1 KO mice fed on a HF diet, we measured the concentration of T3 in blood samples to evaluate a possible endocrine mechanism leading to increased thermogenesis. As presented in Table 2 , no significant differences in T3 concentrations were observed between strains in either diet. Next, we evaluated markers of thermogenesis in two organs involved in heat production. The expression of the thermogenesisinducing protein, UCP1, was significantly increased in BAT of TNFR1 KO mice ( Fig  5A) . This expression was independent of increased mitochondria number, since cytochrome C, a marker of mitochondriogenesis, was similar between strains (Fig. 5B) . Further evidence of greater thermogenesis were increased relative size of BAT ( Fig. 5C and Fig. 5D ; 35±12% heavier in TNFR1 KO as compared to C57BL/6J mice under HF diet, n = 5; p<0.05), which also displayed a more reddish color than BAT of C57BL/6J, and reduction of fat droplets, as determined by histological analysis (Fig. 5E and Fig. 5F ). Skeletal muscle thermogenesis was also increased in TNFR1 KO mice. This was evidenced by increased UCP3 expression (Fig. 5G ) and increased O 2 consumption, as determined by skeletal muscle mitochondria respiration assay (Fig. 5I) . As in BAT, the level of cytochrome C was similar between strains, suggesting no major change in mitochondria number (Fig. 5H) .
Inhibition of TNF- activity in the hypothalamus
increases diet-induced thermogenesis. The hypothalamus controls thermogenesis by modulating the tonus of adrenergic neural connections to thermogenic tissues, such as BAT and skeletal muscle. To evaluate whether the mechanisms involved in the protection against obesity and increased thermogenesis in TNFR1 KO may be, at least in part, dependent upon the hypothalamic actions of TNF-, Wistar rats fed on a HF diet were treated icv with the anti-TNF- monoclonal antibody, infliximab, for seven days. As shown in Fig. 6A , the inhibition of TNF- in the hypothalamus resulted in increased oxygen consumption, whereas the effects on carbon dioxide production and RER were not significant ( Fig. 6B and 6C ).
Discussion
The role of TNF- in the genesis of insulin resistance has been a matter of intense investigation over the last 20 years (4). Initially, it was thought that this cytokine of the innate immune system would be produced by activated macrophages and adipocytes during the progression of adipose tissue hypertrophy. As such, TNF- and other inflammatory cytokines produced in obesity would be the result of body mass gain and, only after the installation of obesity, they would act in insulin sensitive tissues to promote insulin resistance. However, recent studies have provided evidence for the triggering of an innate immune response much before obesity installation (16) (17) (18) (19) (20) . Nutrients, such as fatty acids, can activate signal transduction through TLR2 and TLR4 and also endoplasmic reticulum stress, leading to increased pro-inflammatory gene transcription (20, 21) . In addition, in the hypothalamus, short-term exposure to fatty acids can activate TLR4 signaling and endoplasmic reticulum stress, leading to local production of inflammatory factors and also to apoptosis of neurons involved in the control of energy homeostasis (17, 19, 22, 23) . Thus, TNF- and other inflammatory cytokines play a central role not only in the development of insulin resistance and diabetes, but also in the genesis of obesity.
The experimental inhibition of TNF- by a number of genetic and pharmacological approaches improves insulin resistance and also has an impact on body mass gain (8, 24) . However, long-term inhibition of TNF- in humans, as for the treatment of rheumatoid arthritis and Crohn's disease, may have serious infectious outcomes, discouraging its clinical use for metabolic diseases (25) . Nevertheless, defining the details of TNF- action in obesity and insulin resistance may provide the basis for the development of novel strategies for treating these prevalent diseases.
We herein evaluated the role of TNFR1 in diet-induced obesity. This receptor is expressed in most cells of the body and is the main receptor responsible for transducing the TNF- signal, leading to both inflammatory and apoptotic outcomes (7) . Previous studies have shown that knockout of TNFR1 protects genetically obese ob/ob mice from insulin resistance (9) . However, most cases of obesity in human populations are due to combined effects of environmental and genetic factors. Monogenic defects leading to obesity are extremely rare in humans and therefore, analysis of animal models such as ob/ob and db/db mice must be interpreted with caution. In our opinion, the data we present using mice with obesity induced by a dietary approach, offers a more realistic view of the effect of TNF- signal transduction in obesity than those data obtained with the monogenic determined obesity models.
Initially we observed that, when fed on a high-fat diet, TNFR1 KO mice do not become obese even in face of an increased caloric intake. The protection against dietinduced obesity resulted in normal blood concentrations of insulin and leptin, indicating a preserved response to both these hormones. A reduction in blood insulin level was also obtained when ob/ob mice were made TNFR1 deficient (9) . However, in this case, the reduction was partial, probably because the animals retained their obese phenotype (9) .
In previous studies employing mice with combined defects of the TNFR1 and TNFR2 expressions, the role for TNFR2 upon insulin sensitivity was proven to be minimal (9) . Here, we excluded a role for TNFR2 in dietinduced obesity since no phenotypic modification was obtained by blocking TNFR2 activity in control and TNFR1 KO mice.
The protection against diet-induced obesity in TNFR1 KO was, at least in part, due to reduced visceral fat accumulation and reduced mean adipocyte size. Interestingly, in another genetically-manipulated animal model lacking the innate immune system receptor, TLR4, protection against obesity was also accompanied by reduction of adipose tissue mass and reduction of mean adipocyte size (16) .
Leptin action in the hypothalamus is one of the main players in the coupling of caloric intake and energy expenditure (26) . The normal blood concentration of leptin in TNFR1 KO mice fed on a HF diet suggests an adequate response to this hormone. This was tested at the functional and molecular levels. First we showed that leptin retained its capacity to acutely inhibit food intake in TNFR1 KO mice treated with the HF diet. In addition, there was an increased molecular response to leptin, as evaluated by the activation of JAK2, STAT3 and FOXO1. A number of previous studies have explored the outcomes of defective leptin signaling through the JAK2/STAT3 and PI3K/ Akt/FOXO1 signaling pathways (23, 26) . Acting in concert, these pathways control neurotransmitter expression and release in synaptic terminals (27) . Under leptin resistance, reduced activation of JAK2/ STAT3 and PI3K/Akt/FOXO1 pathways contribute to an anomalous expression of key hypothalamic neurotransmitters (28, 29). In TNFR1 KO mice fed on a HF diet, the levels of POMC were reduced, while the levels of NPY and TRH were increased. The increased expression of NPY and reduced expression of POMC were expected since TNFR1 KO mice are hyperphagic. However, the increased expression of TRH was unexpected because it is, at least in part, inhibited by NPY and stimulated by POMC. Previous studies have shown that leptin can affect TRH expression through two distinct mechanisms: first, a direct activation of the ObR in TRH neurons, and second, indirectly through -MSHinduced MC4 activation. In lean, normoleptinemic subjects, the leptindependent TRH expression is under homeostatic control. Conversely, in dietinduced obesity, with the installation of hypothalamic leptin resistance, a reduction of THR levels was expectable. What is interesting about this regulation is that in TNFR1 KO mice the drop of TRH levels was of a significantly lesser magnitude than in control mice. Thus, we believe this phenomenon plays a role in the relative increased thermogenesis of TNFR1 KO mice.
The mechanisms involved in TRH-induced thermogenesis are the regulation of thyroid function and the modulation of adrenergic tonus to peripheral thermogenic organs, such as brown adipose tissue and skeletal muscle (30). In the TNFR1 KO mice, no significant change in T3 blood concentration was detected. However, in respirometry there was a significant increase in O 2 consumption, which was accompanied by increased UCP1 expression in BAT and increased UCP3 in skeletal muscle. Taken together, these data suggest that, in the absence of TNFR1, thermogenesis is increased by modulation of proteins involved in energy expenditure in peripheral organs, with no major involvement of thyroid function.
To explore the hypothesis of hypothalamic regulation of thermogenesis through TNF- signaling, rats fed on the HF diet were icv treated with the anti-TNF- monoclonal antibody, infliximab, and respirometry was performed. According to this experiment, in the absence of hypothalamic TNF- activity in the obese state, an increase of O 2 consumption is obtained, suggesting increased energy expenditure.
At high concentration, as in sepsis, TNF- increases thermogenesis producing fever and energy wastage (6, 31) . However, at low concentration, as happens in obesity, TNF- produces an anti-thermogenic effect. This is evidenced by reduced relative thermogenesis in obesity (32) and by reduced thermogenesis in animals treated with a low dose of exogenous TNF- (33). These dosedependent effects of TNF- on thermogenesis, may depend at least in part on its hypothalamic actions that control the local activity of leptin and insulin (12) .
Many of the phenotypic outcomes obtained when TNFR1 KO mice are exposed to a HF diet are similar to the results obtained when feeding TLR4 loss-of-function mutated mice on the same diet (16) . Since diet-induced hypothalamic inflammation is triggered by local activation of TLR4 signaling, leading to a complex cellular response that involves endoplasmic reticulum stress, cytokine production and apoptosis (17, 22) , we suspect that hypothalamic production of TNF-, and its signaling through TNFR1 are amongst the most important phenomena linking high-fat diet consumption and obesity.
The present study defines TNF- signaling through TNFR1 as an important mechanism in diet induced obesity, controlling predominantly energy expenditure. Legends for the figures Uncoupling protein 1 (UCP1) (A) and cytochome C (Cyt-C) (B) were determined by immunoblot in total protein extract samples of brown adipose tissue (BAT) of control (CT) and TNFR1 KO (KO) mice fed for eight weeks on standard rodent chow (SC) or high-fat diet (HF). (C) Macroscopic aspect of the BAT and the mass of BAT relative to total body mass (D) were evaluated at the end of the experimental period, as well as the microscopic aspect of BAT stained by the hematoxylin-eosin method (E) and the relative quantification of fat area in histological samples (F). Uncoupling protein 3 (UCP3) mRNA (G) and Cyt-C protein (H) were determined in skeletal muscle by real-time PCR and immunoblot, respectively. Oxygen consumption by skeletal muscle mitochondria was determined by an ex vivo respirometry assay (I). In all experiments, n = 5; *p<0.05. In A, B and H, membranes were rebloted with anti--actin antibody. Figure 6 . Oxygen consumption (A), carbon dioxide production (B) and respiratory exchange ratio (RER) (C) were determined. Wistar rats fed on standard rodent chow (SC) or high-fat diet (HF and HFI) for eight weeks and treated icv with saline (SC and HI) or infliximab (0.6 g/dose; 2.0 L once a day for seven days) (HFI). N = 5; *p<0.05.
